Global expert panel publishes guidance on deliberative processes for health technology assessment

7 June 2022 - Value in Health announced today the publication of guidance regarding the establishment or improvement of deliberative ...

Read more →

NICE sets out further details on menopause guideline update

27 May 2022 - NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where ...

Read more →

Review of discount rate in the PBAC Guidelines

25 May 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment ...

Read more →

EMA guidance supports development of new antibiotics

24 May 2022 - As part of its efforts to support a global approach to the development of new antimicrobial medicines, ...

Read more →

Methods paper: new version 6.1 becomes effective – English translation now available

2 May 2022 - The amendments concern, among other things, the approach to evidence searches for clinical practice guidelines. New ...

Read more →

New handbook on health economic assessments of medical devices

4 May 2022 - TLV performs health economic assessments of medical technology products at the request of the Medical Technology Product ...

Read more →

Consultation now open - review of base case discount rate at 3A.1 of the PBAC Guidelines

5 April 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment ...

Read more →

Updated procedures and guidelines for company submissions to ACE

25 March 2022 - Version 1.1 of ACE's "Procedures and guidelines for company submissions to the Agency for Care Effectiveness for ...

Read more →

FDA drafts guidance on genome editing, CAR T cell therapies

16 March 2022 - The U.S. FDA has issued two draft guidances addressing the development of human gene therapy products that ...

Read more →

Assessing unexpected circumstances that lead to modifications in clinical trial design, conduct, or analysis application of the CONSERVE Reporting Guideline

1 March 2022 - In the COVID-19 Dexamethasone (CoDEX) randomised clinical trial, which studied a sample of critically ill patients with ...

Read more →

NICE publishes new combined methods and processes manual and topic selection manual for its health technology evaluation programmes

31 January 2022 - Changes to the way medicines and other health technologies are evaluated by NICE have now been incorporated ...

Read more →

Method paper: new version 6.1 comes into force

24 January 2022 - The innovations concern, among other things, the procedure for evidence searches for medical guidelines. New concept ...

Read more →

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

11 January 2022 - The new CHEERS 2022 statement replaces previous CHEERS reporting guidance.  ...

Read more →

NICE recommends offering PrEP to people at high risk of HIV for first time

15 December 2021 - People at the highest risk of catching HIV should be offered pre-exposure prophylaxis, NICE has recommended for ...

Read more →

FDA publishes discussion paper and seeks public input on 3D printing of medical devices at the point of care

10 December 2021 - Today, the U.S. FDA published a discussion paper regarding 3D printing medical devices at the point of ...

Read more →